Alkermes Plc

ALKSNASDAQ NMS - GLOBAL MARKET

Biotechnology

IPO 1991-07-16Country IEwww.alkermes.com

$52.11

+0.39 (+0.75%)

Current Price

$52.11

Daily Change

+0.39 (+0.75%)

Volume

Prev Close

$51.72

Key Statistics

Market Cap

$8.62B

Enterprise Value

$9.98B

Shares Outstanding

167M

Beta

0.26

P/E (TTM)

57.77

Forward P/E

PEG Ratio

P/B

2.54

P/S

5.65

EV / EBITDA

47.65

EPS (TTM)

$0.90

Dividend Yield

52-Week High

$55.67

52-Week Low

$25.17

Avg Volume (3M)

2.37M

Float

Financial Health

Revenue (TTM)

$1.57B

Gross Margin

86.63%

Operating Margin

12.28%

Net Margin

ROE

8.82%

ROA

5.39%

Debt / Equity

Current Ratio

3.55

Free Cash Flow

Earnings History

PeriodEPS EstimateActual EPSBeat / MissSurprise %
2026-03-31$-0.58$-0.40Beat+30.87%
2025-12-31$0.35$0.29Miss-16.95%
2025-09-30$0.31$0.49Beat+59.82%
2025-06-30$0.39$0.67Beat+72.37%

Analyst Ratings

Consensus · 23 analysts

Buy 19 (83%)Hold 3 (13%)Sell 1 (4%)

Insider Activity

Recent Sells

NameSharesPriceDate
Gaffin David Joseph-2,034$54.032026-07-06
Hopkinson Craig C.-700$52.132026-07-01
Hopkinson Craig C.-8,300$51.462026-07-01
Wright Christopher I-2,000$45.102026-06-12
Gaffin David Joseph-2,034$43.052026-06-04
Hopkinson Craig C.-9,000$41.672026-06-01